Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$85.79 - $126.46 $244,415 - $360,284
-2,849 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$88.49 - $127.55 $3,362 - $4,846
-38 Reduced 1.32%
2,849 $363,000
Q2 2018

Aug 14, 2018

BUY
$60.0 - $85.67 $173,220 - $247,329
2,887 New
2,887 $231,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Voya Financial Advisors, Inc. Portfolio

Follow Voya Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Voya Financial Advisors, Inc. with notifications on news.